确定TRIM11上调器作为阿尔茨海默病的治疗点:贝叶斯网络方法
Alvin Pham1, Sumita Garai2, Tianhua Zhai2
1University of Texas at Austin, Austin, TX, USA.
AMIA ... Annual Symposium proceedings. AMIA Symposium
|February 23, 2026
概括
研究人员确定了TRIM11的潜在遗传调节器,TRIM11是一种与阿尔茨海默氏症 (AD) 相关的蛋白质. 这一发现为AD提供了新的治疗点,通过了解TRIM11如何影响认知功能.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 计算生物学 计算生物学
背景情况:
- 阿尔茨海默氏症 (AD) 的特点是TRIM11的下调.
- 过度表达TRIM11已经显示出在AD小鼠模型中改善认知功能的潜力.
研究的目的:
- 使用先进的计算方法识别TRIM11的潜在遗传调节者.
- 在阿尔茨海默病的背景下探索影响TRIM11表达的调节网络.
主要方法:
- 在公开可用的数据集上使用单细胞和单核RNA测序 (GSE173731,GSE227222).
- 采用概率方法和贝叶斯网络来识别基因调节关系.
- 应用图形学习方法用于网络分析.
主要成果:
- 在分析的两组数据中确定了一组可能调节TRIM11表达的候选基因.
- 这些已识别的基因表明了影响阿尔茨海默病中TRIM11的新型调节途径.
结论:
- 这项研究为调节TRIM11活性提供了潜在的遗传点.
- 这些发现为开发未来阿尔茨海默病治疗策略提供了有希望的途径.
更多相关视频
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.9K
10:02Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Published on: May 28, 2017
28.2K
相关概念视频
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Neural Regulation
43.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.6K
